|
SERBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72680000000347E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.615900E-03 |
| Normal-vs-Stage2 |
6.443900E-02 |
| Normal-vs-Stage3 |
2.37619999999827E-05 |
| Normal-vs-Stage4 |
1.63483999999769E-05 |
| Stage1-vs-Stage2 |
6.682400E-01 |
| Stage1-vs-Stage3 |
1.985530E-02 |
| Stage1-vs-Stage4 |
1.524090E-02 |
| Stage2-vs-Stage3 |
4.095000E-01 |
| Stage2-vs-Stage4 |
3.226200E-01 |
| Stage3-vs-Stage4 |
8.037000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.61550000000422E-05 |
| Normal-vs-AfricanAmerican |
1.71734999999673E-05 |
| Normal-vs-Asian |
6.016200E-01 |
| Caucasian-vs-AfricanAmerican |
8.717500E-02 |
| Caucasian-vs-Asian |
5.079000E-01 |
| AfricanAmerican-vs-Asian |
1.516560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.175350E-04 |
| Normal-vs-Female |
1.610690E-04 |
| Male-vs-Female |
8.567800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.422000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.420080E-03 |
| Normal-vs-Age(61-80Yrs) |
4.16309999999864E-05 |
| Normal-vs-Age(81-100Yrs) |
2.43009999999488E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.794000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.752200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.931500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.892400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.139900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.284300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.642600E-01 |
| Normal-vs-Grade 2 |
1.134780E-01 |
| Normal-vs-Grade 3 |
7.03620000042093E-07 |
| Normal-vs-Grade 4 |
2.12420000000879E-06 |
| Grade 1-vs-Grade 2 |
9.421200E-01 |
| Grade 1-vs-Grade 3 |
9.155900E-02 |
| Grade 1-vs-Grade 4 |
6.890400E-02 |
| Grade 2-vs-Grade 3 |
9.91049999999882E-05 |
| Grade 2-vs-Grade 4 |
8.408000E-04 |
| Grade 3-vs-Grade 4 |
3.401000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.268450E-01 |
| Normal-vs-ccB subtype |
6.21530000000092E-05 |
| ccA subtype-vs-ccB subtype |
3.677600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.363200E-04 |
| Normal-vs-N1 |
1.441390E-01 |
| N0-vs-N1 |
9.377000E-01 |
|
|
